BACKGROUND: Altered immune responses are seen in depression, and recent data suggest that similar changes could also be observable in alexithymia. We examined whether the inflammatory markers high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 are independently related to alexithymia or its factors in a population-based sample. METHODS: This study formed a clinical part of the Kuopio Depression (KUDEP) general population study focusing on the mental health of a general population of adults aged 25-64 years (n = 308). Alexithymia was measured using the Toronto Alexithymia Scale (TAS-20), and depressive symptoms were assessed using the Beck Depression Inventory (BDI-21). RESULTS: The levels of IL-6 (in picograms per milliliter) and hs-CRP (in milligrams per liter) were significantly higher in alexithymic than in nonalexithymic subjects (IL-6 effect size, ES: 0.50; hs-CRP ES: 0.27). The BDI scores, hs-CRP and IL-6 explained 33.5% of the variation in TAS scores in the whole study population. According to logistic regression analysis, hs-CRP but not IL-6 increased the likelihood of belonging to the alexithymic group. This observation remained unaltered after additional adjustments for chronic inflammation-related disorders, the use of inflammation-modulating medications and depressive symptoms. CONCLUSIONS: Our findings suggest that the association between hs-CRP and alexithymia resembles that observed in depressed patients. It is, however, independent of depressive symptoms. These findings widen our view on the stress-alexithymia concept.
BACKGROUND: Altered immune responses are seen in depression, and recent data suggest that similar changes could also be observable in alexithymia. We examined whether the inflammatory markers high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 are independently related to alexithymia or its factors in a population-based sample. METHODS: This study formed a clinical part of the Kuopio Depression (KUDEP) general population study focusing on the mental health of a general population of adults aged 25-64 years (n = 308). Alexithymia was measured using the Toronto Alexithymia Scale (TAS-20), and depressive symptoms were assessed using the Beck Depression Inventory (BDI-21). RESULTS: The levels of IL-6 (in picograms per milliliter) and hs-CRP (in milligrams per liter) were significantly higher in alexithymic than in nonalexithymic subjects (IL-6 effect size, ES: 0.50; hs-CRP ES: 0.27). The BDI scores, hs-CRP and IL-6 explained 33.5% of the variation in TAS scores in the whole study population. According to logistic regression analysis, hs-CRP but not IL-6 increased the likelihood of belonging to the alexithymic group. This observation remained unaltered after additional adjustments for chronic inflammation-related disorders, the use of inflammation-modulating medications and depressive symptoms. CONCLUSIONS: Our findings suggest that the association between hs-CRP and alexithymia resembles that observed in depressedpatients. It is, however, independent of depressive symptoms. These findings widen our view on the stress-alexithymia concept.
Authors: Benjamin P Chapman; Kevin Fiscella; Ichiro Kawachi; Paul Duberstein; Peter Muennig Journal: J Psychosom Res Date: 2013-08-06 Impact factor: 3.006
Authors: Cédric Lemogne; Silla M Consoli; Béatrice Geoffroy-Perez; Mireille Coeuret-Pellicer; Hermann Nabi; Maria Melchior; Frédéric Limosin; Marie Zins; Pierre Ducimetière; Marcel Goldberg; Sylvaine Cordier Journal: Psychosom Med Date: 2013-03-19 Impact factor: 4.312
Authors: Teemu Rissanen; Soili M Lehto; Jukka Hintikka; Kirsi Honkalampi; Tarja Saharinen; Heimo Viinamäki; Heli Koivumaa-Honkanen Journal: BMC Psychiatry Date: 2013-08-01 Impact factor: 3.630
Authors: Jani Kajanoja; Max Karukivi; Paula Mustonen; Noora M Scheinin; Susanna Kortesluoma; Ana João Rodrigues; Hasse Karlsson; Linnea Karlsson Journal: Front Psychiatry Date: 2020-05-13 Impact factor: 4.157
Authors: Francesco Vadini; Federica Sozio; Giordano Madeddu; Giuseppe De Socio; Paolo Maggi; Giuseppe Nunnari; Francesca Vichi; Paola Di Stefano; Elisa Tracanna; Ennio Polilli; Antonina Sciacca; Bernardetta Zizi; Vincenzo Lai; Claudio Bartolozzi; Maria Elena Flacco; Paolo Bonfanti; Francesca Santilli; Lamberto Manzoli; Giustino Parruti Journal: Open Forum Infect Dis Date: 2019-07-27 Impact factor: 3.835